-
Product Insights
Angiosarcoma – Drugs In Development, 2023
Global Markets Direct’s, ‘Angiosarcoma - Drugs In Development, 2023’, provides an overview of the Angiosarcoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Angiosarcoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Cutaneous Angiosarcoma – Drugs In Development, 2023
Global Markets Direct’s, ‘Cutaneous Angiosarcoma - Drugs In Development, 2023’, provides an overview of the Cutaneous Angiosarcoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cutaneous Angiosarcoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...